Metraipolis › archive › dc_88442efaee10

Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia — Europe PMC PMID:40884550

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40884550
DOI
10.1007/s00228-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-10T06:28:59.031Z
SHA-256 of the archived text
ea1549144983e227d5c8e4a8303dad44d9be892790f8b76e1e81ab019878cf20
Stable URL of this page
https://metraipolis.com/documento/dc_88442efaee10

How to cite

Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia — Europe PMC PMID:40884550 — Europe PMC (en), https://europepmc.org/article/MED/40884550 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_88442efaee10 (Metraipolis archive dc_88442efaee10, sha256 ea1549144983e227d5c8e4a8303dad44d9be892790f8b76e1e81ab019878cf20)
BibTeX
@misc{dc88442efaee10,
  title = {Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia — Europe PMC PMID:40884550},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40884550},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_88442efaee10; sha256 ea1549144983e227d5c8e4a8303dad44d9be892790f8b76e1e81ab019878cf20},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40884550. Agents can read the archived copy with the MCP tool read_document.